Press releases
- Press releases
- Browse
Press releases
Excellence Recognized for Pharmalicensing's Industry Information, Company and Technology Profiles, and Impressive Number of Deals Done More
Trial in mild to moderate ulcerative colitis patients More
REORGANIZATION - FOCUS ON CORE BUSINESS More
PALONOSETRON OUTLICENCED IN NORTHAMERICA More
COMPLETION OF PATIENT ENROLLMENT FOR FIRST PALONOSETRON PHASE 3 PIVOTAL TRIAL More
Andrx Receives Final FDA Marketing Approval for Generic Prilosec More
Highlights include developments for treatment of IBS, Obesity, IBD, Mucositis More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2008 - 148 pages - $1,740
Jun 2006 - 278 pages - $2,495
Dec 2010 - 30 pages - $500
Dec 2010 - 41 pages - $500
Mar 2011 - 41 pages - $500
Dec 2010 - 40 pages - $500
Mar 2011 - 40 pages - $500
Nov 2010 - 933 pages - $1,495
Nov 2010 - 324 pages - $1,495
Nov 2011 - 7 pages - $3,835
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Appendicitis
- Cholangitis, sclerosing
- Colitis
- Colitis, ulcerative
- Constipation
- Crohn's disease
- Diarrhea
- Dyspepsia
- Electrolyte replacement
- Emesis
- Emesis, motion
- Esophagitis
- Flatulence
- Food poisoning
- Gastritis
- Gastroesophageal reflux disorder
- Gastrointestinal (other)
- Gastrointestinal secretions
- Gastroprokinetic
- Helicobacter pylori
- Inflammatory bowel disease
- Irritable bowel syndrome
- Nausea
- Pancreatitis
- Ulcer
- Ulcer, gastric
- Ulcer, gastroduodenal
- Ulcer, peptic
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us